Laywers didn't take $1.2M of the $8m settlement they were contractually due on RJR settlement. In negotiations completed just 3 weeks ago they agreed to take their $1.2m out of future royalty payments. Star says there are no licensing agreements "at this time".
Star refers to Hopkins in clear language. Indicates peer reviewed thyroid article as being a "major" accomplishment
Star indicates that USA stuff is not an issue.
Star indicates the disgusting legal fees on the shareholder stuff are anticipated to be reimbursed by insurance.
Star has capital and new buy in to carry thru Q2 2014
Star references potential pharma product in a new sentence.
Probably best report in the 5 years I have been floating around.
I like that 1.8m in short covering drove price up... Pre release... and lack of stock borrow has retail shorts paying thru nose again. I think Anatabine may have a couple of potential partners getting serious.
Dunno anything more than broad in thong, which is zero, but seems like sumptin cooking... On a few fronts.